Bank of New York Mellon’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-138
Closed -$9.66K 4466
2023
Q1
$9.66K Hold
138
﹤0.01% 4362
2022
Q4
$11.2K Hold
138
﹤0.01% 4415
2022
Q3
$11K Hold
138
﹤0.01% 4503
2022
Q2
$22K Sell
138
-1
-0.7% -$237 ﹤0.01% 4485
2022
Q1
$52K Hold
139
﹤0.01% 4514
2021
Q4
$54K Hold
139
﹤0.01% 4489
2021
Q3
$104K Hold
139
﹤0.01% 4329
2021
Q2
$145K Sell
139
-17
-11% -$20.3K ﹤0.01% 4156
2021
Q1
$233K Sell
156
-13
-8% -$18.9K ﹤0.01% 4007
2020
Q4
$179K Sell
169
-9
-5% -$8.18K ﹤0.01% 4004
2020
Q3
$128K Buy
178
+58
+48% +$55.3K ﹤0.01% 3930
2020
Q2
$83K Sell
120
-70
-37% -$31.4K ﹤0.01% 3924
2020
Q1
$64K Buy
190
+120
+171% +$47.3K ﹤0.01% 3933
2019
Q4
$57K Hold
70
﹤0.01% 4091
2019
Q3
$99K Sell
70
-4
-5% -$6.41K ﹤0.01% 4030
2019
Q2
$156K Buy
+74
New +$150K ﹤0.01% 3970

Other funds holding YCBD

Bank of New York Mellon's YCBD Position: Q2 2023 in Review

Bank of New York Mellon sold out of cbdMD (YCBD) in Q2 2023, closing a stake of 138 shares — an estimated $9.66K sold.

Bank of New York Mellon first reported a position in YCBD in Q2 2019 and held it in 16 quarters. The position peaked at $233K in Q1 2021. 20 funds tracked by Wall St. Rank hold YCBD as of Q2 2023.

  • Bank of New York Mellon reported no remaining cbdMD position as of Q2 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 138 cbdMD shares in Q2 2023, an estimated $9.66K.
  • Bank of New York Mellon first reported a position in cbdMD in Q2 2019 and held it in 16 quarters.
  • Bank of New York Mellon's cbdMD position peaked at $233K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held cbdMD as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.